SBF2 and acute myeloid leukemia: ANRIL, RP11-732M18.3, LNC_104449, CASC15, CCDC26, DANCR, LINC00467, MIR9-3HG, AL035071.1, AP001042.1, RP11-395P13.6-001, FAM30A, H22954, LEF1-AS1, LINC00152, LINC00239, LINC00265, LINC00319, LINC00504, LINC00899, LINC00926, LNC177417, LRRC75A-AS1, MALAT1, NEAT1, PANDAR, PILNA, RP11-222k16.2, RP11-305O.6, SBF2-AS1, TUG1, UCA1, ZFAS1 have potential oncogenic roles in AML.